Purpose: The prevalence of osteoporosis in elderly individuals is high, and osteoporosis is strongly associated with chronic inflammation. The monocyte-to-high-density lipoprotein ratio (MHR) is acknowledged as a marker for assessing systemic inflammation and oxidative stress, and changes in the MHR are associated with many chronic disease prevalent among the elderly population. This study investigated the relationships between the MHR and the incidence of osteoporosis in older adults, along with its predictive value. Patients and Methods: Data from 563 participants aged ≥ 70 years were retrospectively analysed. The haematological parameters were evaluated via established methodologies, utilizing fasting blood samples collected from the participants. The absolute monocyte count was used to calculate the MHR (MHR=monocyte/HDL-C). BMD was measured by dual-energy X-ray absorptiometry. The results were evaluated via comparative statistical analyses, Spearman correlation, logistic regression analyses, and receiver operating characteristic (ROC) curve analysis. Results: The differences in the MHR were statistically significant among the osteoporosis groups (p < 0.001). Spearman correlation analysis revealed a positive correlation between the MHR and BMD. Furthermore, stratifying the sample into four groups on the basis of quartiles of MHR (M1, M2, M3, and M4) revealed a decreased risk of osteoporosis in the highest quartile compared with the lowest quartile (p < 0.001). Multiple logistic regression analysis revealed that BMI and the MHR were independent risk factors for osteoporosis. The area under the ROC curve and the cut-off value of the MHR were 0.710 and 0.308(109/mmol), with specificity and sensitivity of 0.599 and 0.735, respectively (95% CI: 0.668~0.752, p < 0.0001). Conclusion: A low MHR was associated with a greater risk of senile osteoporosis. In clinical practice, the MHR has shown predictive value for senile osteoporosis, contributing to early intervention and treatment of this disease.
Background and purpose: Alzheimer’s disease (AD) is a neurodegeneration disease. The previous work from our research group demonstrated the neuroprotective effects of tripchlorolide (T4) in AD animal models. Materials and methods: Neprilysin (NEP) is known as an important physiological amyloid-β protein (Aβ) peptide-degrading enzyme in the brain due to its apparent rate-limiting function. In this study, we explored the effect of NEP on AD model N2a/APP695 cells. Western blots and enzyme-linked immunosorbent assays were performed to assess the expression of proteins, while quantitative real-time polymerase chain reaction assays were used to evaluate RNA levels. Cell vitality was detected by the MTT assay, and reactive oxygen species (ROS) levels were assessed using a ROS activity assay kit. Results: We discovered that T4 was able to enhance the enzyme activity of NEP. T4 administration decreased the protein levels of the soluble amyloid precursor protein. In further experiments, we found that by using thiorphan the secretion of Aβ, oxidative stress, nitrosative stress, and inflammatory factors, which were suppressed by T4, were reversed. Due to its ability to attenuate Aβ generation and to protect neurons against the neurotoxicity of Aβ, T4 may be a potential therapy in the regulation of Aβ-related pathology in AD by affecting NEP activity. Conclusion: Tripchlorolide attenuates Aβ generation by inducing NEP activity in N2a/APP695 cells.
The duration of cardiac arrest (CA) and the level of lactate within 24 h of CA are both associated with a poor prognosis in patients who have received cardiopulmonary resuscitation (CPR) but their combined effect remains unclear. Assess the independent associations of CA duration and post-resuscitation lactate level with 6-month mortality in patients undergoing CPR. CA duration and post-resuscitation lactate level have a multiplicative and additive interaction, such that their combined effect on mortality is greater than the sum of their individual effects. A retrospective cohort study was conducted on patients who underwent CPR and achieved return of spontaneous circulation (ROSC) in the emergency department (ED) of XX Hospital from January 2018 to June 2022. Inclusion criteria included: (1) aged ≥ 18 years; (2) successful CPR with ROSC lasting ≥ 1 h; (3) available CA duration and post-resuscitation lactate level data; (4) 6-month follow-up completed. Exclusion criteria included: (1) systolic blood pressure ≤ 40 mmHg on ED presentation; (2) pre-existing severe liver or kidney dysfunction; (3) missing key data. CA duration and the level of lactate within 24 h of CA were independently associated with the mortality of post-arrest survivors of CPR at six months (odds ratio [OR] = 1.065; 95% confidence interval [CI]: 1.032-1.098; P < 0.001, and OR = 0.323; 95% CI: 0.104-0.997; P = 0.049, respectively). The sensitivity and specificity of CA duration for the prognosis of death were 68.0% and 88.4%, respectively, using a cut-off value of 20.5 min. The area under curve (AUC) was 0.805 (95% CI: 0.745-0.866). Furthermore, these factors were associated, in a multiplicative manner, with death, with an adjusted OR of 1.010 (95% CI: 1.006-1.013). The additive interaction between these factors was associated with death, with a synergy index (SI) of 1.0985 (95%: CI 1.0746-1.1229). CA time and lactate level after CA were associated with the six-month mortality of post-arrest CPR survivors and has both multiplicative and additive interaction.
1 January 2026 in International Journal of Genomics
Background: Genome‐wide association studies (GWASs) have revealed that glycoprotein nonmetastatic melanoma Protein B (GPNMB) was associated with Parkinson′s disease (PD). GPNMB has been found in plasma and cerebrospinal fluid, and its levels and the variation of single nucleotide polymorphisms (SNPs) have been linked to disease severity in PD patients. However, whether the altered expression of GPNMB is the cause or the result cannot be identified in the patient samples. Methods: This study applied a Mendelian randomization analysis to explore the causal relationship between GPNMB and PD. The blood GPNMB mRNA level from the expression quantitative trait loci (eQTL) dataset and the plasma GPNMB protein level from the protein quantitative trait loci (pQTL) acted as the exposure. PD′s GWAS dataset from the International Parkinson′s Disease Genomics Consortium including 33674 PD cases and 449056 normal controls was applied as the outcome. Results: MR analysis with the inverse‐variant weighted method (IVW, OR = 1.416, p = 1.39 e − 06) and the weighted median methods (WM, OR = 1.430, p = 4.47 e − 07) showed that the plasma GPNMB protein expression was linked to a higher risk of PD. We also discovered a significant association between the blood mRNA level of GPNMB and PD risk. The IVW (OR = 1.243, p = 3.64 e − 09) and WM (OR = 1.237, p = 5.11 e − 08) methods share similar results. Secondary MR analysis further reveals causality between GPNMB pQTL/eQTL and brain volume traits. Conclusions: The study demonstrated a significant association between plasma GPNMB protein (pQTL) and mRNA level (eQTL) with PD. Further secondary MR analysis revealed causality between GPNMB pQTL/eQTL and brain volume traits.